Myriad Genetics Announces Regulatory Approval of the BRACAnalysis® Diagnostic System in Japan for Breast Cancer Patients

    NEXT STORY
    Arvinas Appoints Laurie Smaldone Alsup, M.D., to Board of Directors
    PREV STORY
    Immuron Plans Phase 3 trial for IMM-124E to Prevent Travelers’ Diarrhea
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    NewLink Genetics to Present at the 36th Annual J.P. Morgan Healthcare Conference

    AMES, Iowa, Dec. 21, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced today that ...

    author_avatar
    NASDAQ Market News

    BriaCell Appoints Richard J. Berman to Board of Directors

    author_avatar
    NASDAQ Market News

    Rafael Pharmaceuticals Announces Initiation of Patient Enrollment for Phase II Clinical Trial of CPI-613 for Patients with Relapsed or Refractory Burkitt Lymphoma/Leukemia

    Newark, NJ, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in ...

    author_avatar
    NASDAQ Market News